- All Drug Categories
- Home
- Anti-cancer Drugs
- Healthcare Products
- Medical Information
- Statement
The use of Encorafenib requires strict monitoring of adverse reactions and drug interactions, involving various precautions such as cardiac tox...
The daily dosage of Encorafenib should be determined according to the indications, usually a single oral dose of 450mg (melanoma/NSCLC) or 300m...
Fumarate propofol tenofovir tablets (Vemlidy) are an antiviral drug used to treat chronic hepatitis B virus (HBV) infection. They effectively i...
Fumarate propofol tenofovir tablets (Vemlidy) are antiviral drugs used to treat chronic hepatitis B. When using them, attention should be paid ...
Selumetinib is a MEK inhibitor mainly used to treat type 1 neurofibromatosis related plexiform neurofibromatosis. Its common side effects inclu...
Selumetinib is a MEK1/2 inhibitor mainly used to treat type 1 neurofibromatosis related plexiform neurofibromatosis. It exerts anti-tumor eff...
Lenvatinib is a multi-target tyrosine kinase inhibitor mainly used to treat malignant tumors such as thyroid cancer, hepatocellular carcinoma, ...
The use of Lenvatinib should focus on adverse reactions such as hypertension and proteinuria, and regular monitoring and adjustment of dosage a...
Tucatinib is an anticancer drug targeting HER2 protein, which is mainly used to treat HER2 positive breast cancer and colorectal cancer. Its si...
The use of Tucatinib should focus on preventing diarrhea, hepatotoxicity, and reproductive risks. The dosage should be adjusted according to to...
